A Hypergraph Convolutional Network with Explicit High-Order Interaction Information Extraction for Drug Repositioning.

Xiang Du, Xinliang Sun, Min Zeng, Wei Tan, Min Li
{"title":"A Hypergraph Convolutional Network with Explicit High-Order Interaction Information Extraction for Drug Repositioning.","authors":"Xiang Du, Xinliang Sun, Min Zeng, Wei Tan, Min Li","doi":"10.1109/TCBBIO.2025.3619038","DOIUrl":null,"url":null,"abstract":"<p><p>Drug repositioning, a promising strategy in drug development, aims to identify new indications for existing drugs, reduce costs, and lower safety risks. Due to their unique advantages in modeling higher-order relations among nodes, hypergraphs and hypergraph neural networks (HGNN) have become increasingly popular in drug repositioning. However, most HGNN-based methods fail to account for the diverse relations generated during the convolution process and do not explicitly model high-order interactions, limiting their ability to capture high-order interaction information adequately. To address these limitations, we propose a hypergraph convolutional network with explicit high-order interaction extraction for drug repositioning, termed HGCNDR. Our model introduces a relation-aware hypergraph convolution operation to handle distinct relation types and an effective strategy using the Hadamard product to model high-order interactions among drugs and diseases, efficiently extracting the resulting high-order interaction information. Specifically, HGCNDR constructs two feature graphs and a hypergraph based on drug similarity features, disease similarity features, and drug-disease association networks. HGCNDR then employs graph convolutional networks to extract embeddings from the feature graphs, while using the relation-aware hypergraph convolution operation and the strategy to extract structural and high-order interaction information embeddings from the hypergraph. Additionally, to preserve the common semantics between the embeddings extracted from the feature graphs and the hypergraph, HGCNDR introduces a consistency constraint. The experimental results demonstrate that HGCNDR has competitive performance compared to several baseline methods. Moreover, case studies on Alzheimer's disease and Breast carcinoma confirm that HGCNDR is able to retrieve more actual drug-disease associations in the top prediction results.</p>","PeriodicalId":520987,"journal":{"name":"IEEE transactions on computational biology and bioinformatics","volume":"PP ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE transactions on computational biology and bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/TCBBIO.2025.3619038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Drug repositioning, a promising strategy in drug development, aims to identify new indications for existing drugs, reduce costs, and lower safety risks. Due to their unique advantages in modeling higher-order relations among nodes, hypergraphs and hypergraph neural networks (HGNN) have become increasingly popular in drug repositioning. However, most HGNN-based methods fail to account for the diverse relations generated during the convolution process and do not explicitly model high-order interactions, limiting their ability to capture high-order interaction information adequately. To address these limitations, we propose a hypergraph convolutional network with explicit high-order interaction extraction for drug repositioning, termed HGCNDR. Our model introduces a relation-aware hypergraph convolution operation to handle distinct relation types and an effective strategy using the Hadamard product to model high-order interactions among drugs and diseases, efficiently extracting the resulting high-order interaction information. Specifically, HGCNDR constructs two feature graphs and a hypergraph based on drug similarity features, disease similarity features, and drug-disease association networks. HGCNDR then employs graph convolutional networks to extract embeddings from the feature graphs, while using the relation-aware hypergraph convolution operation and the strategy to extract structural and high-order interaction information embeddings from the hypergraph. Additionally, to preserve the common semantics between the embeddings extracted from the feature graphs and the hypergraph, HGCNDR introduces a consistency constraint. The experimental results demonstrate that HGCNDR has competitive performance compared to several baseline methods. Moreover, case studies on Alzheimer's disease and Breast carcinoma confirm that HGCNDR is able to retrieve more actual drug-disease associations in the top prediction results.

基于显式高阶交互信息提取的超图卷积网络药物重新定位。
药物重新定位是一种很有前途的药物开发策略,旨在为现有药物确定新的适应症,降低成本,降低安全风险。由于在节点间高阶关系建模方面的独特优势,超图和超图神经网络(hypergraph neural networks, HGNN)在药物重新定位中越来越受欢迎。然而,大多数基于hgnn的方法未能考虑到卷积过程中产生的各种关系,并且没有明确地模拟高阶相互作用,从而限制了它们充分捕获高阶相互作用信息的能力。为了解决这些限制,我们提出了一个用于药物重新定位的具有显式高阶相互作用提取的超图卷积网络,称为HGCNDR。我们的模型引入了一个关系感知的超图卷积运算来处理不同的关系类型,并使用Hadamard积来模拟药物和疾病之间的高阶相互作用,有效地提取产生的高阶相互作用信息。具体而言,HGCNDR基于药物相似特征、疾病相似特征和药物-疾病关联网络构建了两个特征图和一个超图。然后HGCNDR利用图卷积网络从特征图中提取嵌入,同时利用关系感知超图卷积运算和策略从超图中提取结构和高阶交互信息嵌入。此外,为了保持从特征图和超图中提取的嵌入之间的公共语义,HGCNDR引入了一致性约束。实验结果表明,与几种基准方法相比,HGCNDR具有较好的性能。此外,对阿尔茨海默病和乳腺癌的案例研究证实,HGCNDR能够在最靠前的预测结果中检索到更多实际的药物-疾病关联。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信